[ET Net News Agency, 16 June 2026] INNOGEN-B (02591) fell 6.7% to HK$8.03.
It hits an intra-day low of HK$8.03, hitting a historical low, and an intra-day high of HK$8.71. The total shares traded was 1.39 million, with a value of HK$11.51m. The active buy/sell ratio is 31:69, with net selling turnover of HK$4.08m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$1.04m, with volume weighted average price of HK$8.315. CITIC SEC BRO accounts for greatest net responsive selling turnover of HK$737,326, with volume weighted average price of HK$8.259.
Basic Information| Nominal | 8.030 | % Chg | -6.74% |
| High | 8.710 | Low | 8.030 |
| Shares Tr | 1.39m | Turnover | 11.51m |
| 10-D SMA | 9.021 | %H.V | 93.961 |
| 20-D SMA | 10.452 | VWAP | 8.268 |
| 50-D SMA | 14.423 | RSI14 | 27.376 |
Status: Hitting a historical low, active buy/sell ratio is 31:69, with net selling turnover of HK$4.08m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 8.03 | -6.74 |
| GENSCRIPT BIO (01548) | 11.44 | -3.05 |
| INNOVENT BIO (01801) | 76.40 | -1.29 |
| XTALPI (02228) | 6.56 | -5.61 |
| WUXI XDC (02268) | 46.20 | -4.35 |
| WUXI BIO (02269) | 29.92 | -3.23 |
| BEONE MEDICINES (06160) | 159.10 | -0.31 |
| SKB BIO (06990) | 425.80 | +1.57 |
| AKESO (09926) | 84.50 | -5.43 |
| REMEGEN (09995) | 68.05 | -5.68 |
(ed)
Nominal 
